Intimation regarding approval for investments in (i) HCG NCHRI Oncology LLP, wholly owned subsidiary for up to Rs. 98 Crore and (ii) Vizag Hospital and Cancer Research Centre Pvt Ltd (Vizag Hospital), a subsidiary of the Company for up to Rs. 155.66 crore for the acquisition of additional stake of 34% in the equity share capital of Vizag Hospital, directly from the selling shareholders..